Review: Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Comparison: 2 Fluticasone/salmeterol (FPS) versus placebo (PLA)
Outcome: 23 Change from baseline in rescue medication usage (puffs/day)